Keyphrases
Molecular Pathways
100%
Point mutation
100%
PAX8
100%
Thyroid Tumor
100%
Follicular Thyroid Carcinoma
100%
KRAS mutation
71%
Galectin-3 (Gal-3)
42%
Follicular Carcinoma
42%
HBME-1
42%
Immunohistochemistry
14%
Immunoreactivity
14%
Young Patients
14%
Cell Tumor
14%
Codon 12
14%
K-ras
14%
HEC-RAS
14%
Non-overlapping
14%
Molecular Methods
14%
Immunophenotyping
14%
Technology-based
14%
N-Ras
14%
Follicular Adenoma
14%
RAS Gene
14%
LightCycler
14%
Medicine and Dentistry
Point Mutation
100%
Peroxisome Proliferator Activated Receptor
100%
Thyroid Tumor
100%
Thyroid Follicular Carcinoma
100%
Galectin 3
42%
Follicular Carcinoma
42%
Immunohistochemistry
14%
Tumor Cell
14%
Immunoreactivity
14%
Adenoma
14%
Codon
14%
Immunophenotyping
14%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Thyroid Tumor
100%
Thyroid Follicular Carcinoma
100%
Galectin 3
42%
Follicular Carcinoma
42%
Neoplasm
14%
Adenoma
14%
Biochemistry, Genetics and Molecular Biology
Point Mutation
100%
Peroxisome Proliferator-Activated Receptor
100%
PAX8
100%
Galectin-3
42%
Codon
14%
Immunoreactivity
14%
Immunophenotyping
14%